These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11533546)

  • 21. Reply: Effect of prophylaxis on fungal infection and costs for high-risk liver transplant recipients.
    Huprikar S
    Liver Transpl; 2008 May; 14(5):709. PubMed ID: 18433053
    [No Abstract]   [Full Text] [Related]  

  • 22. Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients.
    Fortún J; Martín-Dávila P; Montejo M; Muñoz P; Cisneros JM; Ramos A; Aragón C; Blanes M; San Juan R; Gavaldá J; Llinares P;
    Transplantation; 2009 Feb; 87(3):424-35. PubMed ID: 19202450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Itraconazole prophylaxis in lung transplant recipients receiving tacrolimus (FK 506): efficacy and drug interaction.
    Shitrit D; Ollech JE; Ollech A; Bakal I; Saute M; Sahar G; Kramer MR
    J Heart Lung Transplant; 2005 Dec; 24(12):2148-52. PubMed ID: 16364864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation.
    Hellinger WC; Bonatti H; Yao JD; Alvarez S; Brumble LM; Keating MR; Mendez JC; Kramer DJ; Dickson RC; Harnois DM; Spivey JR; Hughes CB; Nguyen JH; Steers JL
    Liver Transpl; 2005 Jun; 11(6):656-62. PubMed ID: 15915482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome.
    Husain S; Muñoz P; Forrest G; Alexander BD; Somani J; Brennan K; Wagener MM; Singh N
    Clin Infect Dis; 2005 Jan; 40(1):89-99. PubMed ID: 15614697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.
    Maertens J
    Eur J Haematol; 2007 Apr; 78(4):275-82. PubMed ID: 17241370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation.
    Borro JM; Solé A; de la Torre M; Pastor A; Fernandez R; Saura A; Delgado M; Monte E; Gonzalez D
    Transplant Proc; 2008 Nov; 40(9):3090-3. PubMed ID: 19010204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevention of mycotic infections in oncology patients with regard to the toxicity of antimycotic agents].
    Doubek M; Mayer J; Horký D; Doubek J; Rácil Z; Vorlícek J
    Vnitr Lek; 2002 Mar; 48(3):248-54. PubMed ID: 11968587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients.
    Fortún J; Martín-Davila P; Moreno S; Barcena R; de Vicente E; Honrubia A; García M; Nuño J; Candela A; Uriarte M; Pintado V
    J Antimicrob Chemother; 2003 Nov; 52(5):813-9. PubMed ID: 14563893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of mycoses in surgical patients -- review of the literature.
    Holzheimer RG; Dralle H
    Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and outcome of fungal infection in patients with severe acute pancreatitis.
    Kochhar R; Ahammed SK; Chakrabarti A; Ray P; Sinha SK; Dutta U; Wig JD; Singh K
    J Gastroenterol Hepatol; 2009 May; 24(5):743-7. PubMed ID: 19220667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients.
    Perera GK; Child FJ; Heaton N; O'Grady J; Higgins EM
    Br J Dermatol; 2006 May; 154(5):868-72. PubMed ID: 16634888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective screening in liver transplant recipients by panfungal PCR-ELISA for early diagnosis of invasive fungal infections.
    Badiee P; Kordbacheh P; Alborzi A; Malekhoseini S; Zeini F; Mirhendi H; Mahmoodi M
    Liver Transpl; 2007 Jul; 13(7):1011-6. PubMed ID: 17600362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liposomal amphotericin B prophylaxis of invasive mold infections in children post allogeneic stem cell transplantation.
    Roman E; Osunkwo I; Militano O; Cooney E; van de Ven C; Cairo MS
    Pediatr Blood Cancer; 2008 Feb; 50(2):325-30. PubMed ID: 17514732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coccidioidomycosis in liver transplantation.
    Blair JE
    Liver Transpl; 2006 Jan; 12(1):31-9. PubMed ID: 16382459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea.
    Sohn HS; Lee TJ; Kim J; Kim D
    Clin Ther; 2009 May; 31(5):1105-15; discussion 1066-8. PubMed ID: 19539111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The place for itraconazole in treatment.
    Maertens J; Boogaerts M
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i33-i38. PubMed ID: 16120632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology of systemic mycoses among renal-transplant recipients in India.
    Tharayil John G; Shankar V; Talaulikar G; Mathews MS; Abraham Abraham M; Punnakuzhathil Thomas P; Korula Jacob C
    Transplantation; 2003 May; 75(9):1544-51. PubMed ID: 12792512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison between two high-dose methylprednisolone schedules in the treatment of acute hepatic cellular rejection in liver transplant recipients: a controlled clinical trial.
    Volpin R; Angeli P; Galioto A; Fasolato S; Neri D; Barbazza F; Merenda R; Del Piccolo F; Strazzabosco M; Casagrande F; Feltracco P; Sticca A; Merkel C; Gerunda G; Gatta A
    Liver Transpl; 2002 Jun; 8(6):527-34. PubMed ID: 12037783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials.
    Bow EJ; Laverdière M; Lussier N; Rotstein C; Cheang MS; Ioannou S
    Cancer; 2002 Jun; 94(12):3230-46. PubMed ID: 12115356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.